Área Sanitaria da Coruña e Cee
Sanitary area
GlaxoSmithKline (Spain)
Madrid, EspañaPublications in collaboration with researchers from GlaxoSmithKline (Spain) (6)
2022
-
Preventing organ damage in systemic lupus erythematosus: the impact of early biological treatment
Expert Opinion on Biological Therapy, Vol. 22, Núm. 7, pp. 821-829
2021
-
Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)
Drugs
-
REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study
Drugs, Vol. 81, Núm. 15, pp. 1763-1774
2010
-
Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959
2008
-
A retrospective study of the effectiveness of lamotrigine in monotherapy for the treatment of epileptic seizures. The ERELMO study
Revista de Neurologia, Vol. 46, Núm. 4, pp. 197-202
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313